Health Sciences

The new U.S. plan to target xylazine-laced fentanyl

Researchers from Penn LDI, in conjunction with the Center for Health Economics of Treatment Interventions for Substance Use Disorder, analyze the plan and raise the question of whether it goes far enough.

From Penn LDI

In the News

The New York Times

What social media does to the teen brain

Frances Jensen of the Perelman School of Medicine examines the impact that social media is having on the brains of teenagers, the first “truly digital generation.”


Hartford Courant

Mistrust of medical professionals harms Black residents’ health. CT professionals are working to improve it

A Perelman School of Medicine study shows that distrust of the health care system is strongly connected with self-reported fair or poor health.


Philadelphia Inquirer

My brother’s recovery from a car crash became a lesson in how to talk to doctors and nurses

Emily Largent of the Perelman School of Medicine writes that communication is part of healing, as she experienced when her brother was in a car accident and unable to notify family himself.


Philadelphia Inquirer

In-hospital strokes like Charlie Manuel’s are common

Steven Messé of the Perelman School of Medicine has been working on a solution to a long-standing problem in stroke care and says that for a variety of reasons in-hospital strokes sometimes are not detected until hours after they occur.


Philadelphia Business Journal

Penn researcher’s Every Cure nonprofit lands ‘game-changing’ support as it works to help patients with uncurable diseases

David Fajgenbaum of the Perelman School of Medicine comments on “game-changer” funding for the nonprofit Every Cure, which he co-founded.